Evaluating the impact of a Risk Evaluation and Mitigation Strategy with tolvaptan to monitor liver safety in patients with autosomal dominant polycystic kidney disease

por Estilo, Alvin, Tracy, LaRee, Matthews, Carol, Riggen, Michele, Stemhagen, Annette, Wilt, Timothy, Krakovich, Anatoliy, Jones-Burton, Charlotte, George, Vinu, McQuade, Robert, Rahman, Mirza
Publicado 2022